Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Expression of Plasma miRNA-133a is Significantly Lower in Acute Coronary Syndrome (ACS) than in Healthy/Non-ACS Subjects

The Indonesian Biomedical Journal · Vol. 16 No. 5 (2024) · hlm. 464–472

DOI
10.18585/inabj.v16i5.3243
ISSN
2085-3297, 2355-9179
Terbit
2024-10-28
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: The current biomarker diagnostic modality for acute coronary syndrome (ACS), cardiac troponin, has several limitations. Emerging studies showed that micro-RNA (miR)-133a was released from infarcted heart to circulation, yet the diagnostic value of miR-133a in ACS demonstrated a conflicting result. Therefore, this study was conducted to investigate the potency of plasma miR-133a as a biomarker candidate of ACS.METHODS: This was a case-controlled study, involving ACS and control subjects. The sociodemographic and clinical characteristics were assessed through medical records. A final of 39 ACS and 31 control subjects (consist of healthy and non-ACS subjects) passed the selection procedure by demonstrating a high purity of RNA. miR-133a from ACS and control subjects were detected by quantitative polymerase chain reaction (qPCR). Expression of miR-133a was evaluated for sensitivity and specificity as an ACS biomarker diagnostic using the receiver operating characteristic (ROC) curve.RESULTS: Plasma miR-133a expression was stably found in ACS subjects. The plasma miR-133a level was lower in ACS than in control subjects. miR-133a effectively distinguished ACS subjects from healthy subjects (AUC=0.911) and exhibited high diagnostic performance, with a sensitivity of 87.1% and specificity of 100% at a cut-off value of 44.035. In an extended model including both control subjects (healthy and non-ACS with comorbid conditions), miR-133a maintained diagnostic significance (AUC=0.874), showing sensitivity of 76.9% and specificity of 100% at a cut-off value of 11.69.CONCLUSION: Plasma miR-133a is significantly lower and effectively distinguishes ACS patients from both healthy individuals and non-ACS individuals with comorbid, with a cut-off value of 11.69. Therefore, plasma miR-133a is suggested to be a good candidate for diagnostic biomarkers of ACS.KEYWORDS: circulating miRNA, miRNA-133a, acute coronary syndrome, diagnostic biomarker

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 231 tautan kepenulisan bersama · 26 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Brawijaya
  • Universitas Islam Negeri Maulana Malik Ibrahim
  • University of Pembangunan Nasional Veteran Jawa Timur
  • Universitas Trisakti
  • Universitas Amikom Purwokerto
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anna Fuji RahimahUniversity of Brawijaya12
Novi KurnianingsihUniversity of Brawijaya10
Mohammad Saifur RohmanUniversity of Brawijaya9
Cholid Tri TjahjonoUniversity of Brawijaya8
Ardian RizalUniversity of Brawijaya8
Budi SatrijoUniversity of Brawijaya7
Setyasih AnjarwaniUniversity of Brawijaya5
Ferry SandraUniversitas Trisakti5
Yoga WaranugrahaUniversity of Brawijaya4
Sasmojo WiditoUniversity of Brawijaya4
Olivia HandayaniUniversity of Brawijaya3
Putri Annisa KamilaUniversity of Brawijaya3
Indra PrasetyaUniversity of Brawijaya3
Mohammad Aris WidodoUniversity of Brawijaya3
Heny MartiniUniversity of Brawijaya2
Dadang HendrawanUniversity of Brawijaya2
Liemena Harold AdrianUniversity of Brawijaya2
Muhammad Rizki FadlanUniversity of Brawijaya2
Teguh AryanugrahaUniversity of Brawijaya2
Pungkas SubarkahUniversitas Amikom Purwokerto1
Irma DamayantiAfiliasi tidak diketahui1
Dias Ayu Budi UtamiAfiliasi tidak diketahui1
Prastyadi Wibawa RahayuAfiliasi tidak diketahui1
Yoseph Budi UtomoUniversity of Brawijaya1
Ryan RamadhanUniversity of Brawijaya1
Renny SuwarniatyUniversity of Brawijaya1
Taufieq Ridlo MakhmudUniversity of Brawijaya1
Faris Wahyu NugrohoUniversity of Brawijaya1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Expression of Plasma miRNA-133a is Significantly Lower in Acute Coronary Syndrome (ACS) than in Healthy/Non-ACS Subjects</dc:title><dc:creator>Ermin Rachmawati</dc:creator><dc:creator>Djanggan Sargowo</dc:creator><dc:creator>Indra Wahyu Saputra</dc:creator><dc:creator>Riskiyah Riskiyah</dc:creator><dc:creator>I Handirosiyanto</dc:creator><dc:creator>Arief Rachman Hakim</dc:creator><dc:creator>Mahrus Ismail</dc:creator><dc:creator>Tarsadi Tarsadi</dc:creator><dc:creator>Syafiq Maulana</dc:creator><dc:creator>Iwal Reza Ahdi</dc:creator><dc:creator>A’ Rofah Nurlina Puspitasari</dc:creator><dc:creator>Syanindita Puspa Wardhani</dc:creator><dc:subject>miR-133a</dc:subject><dc:subject>acute coronary syndrome</dc:subject><dc:subject>plasma microRNA</dc:subject><dc:subject>circulating microRNAs</dc:subject><dc:subject>diagnostic biomarkers</dc:subject><dc:subject>cardiac biomarkers</dc:subject><dc:subject>sensitivity and specificity</dc:subject><dc:description xml:lang="en">BACKGROUND: The current biomarker diagnostic modality for acute coronary syndrome (ACS), cardiac troponin, has several limitations. Emerging studies showed that micro-RNA (miR)-133a was released from infarcted heart to circulation, yet the diagnostic value of miR-133a in ACS demonstrated a conflicting result. Therefore, this study was conducted to investigate the potency of plasma miR-133a as a biomarker candidate of ACS.METHODS: This was a case-controlled study, involving ACS and control subjects. The sociodemographic and clinical characteristics were assessed through medical records. A final of 39 ACS and 31 control subjects (consist of healthy and non-ACS subjects) passed the selection procedure by demonstrating a high purity of RNA. miR-133a from ACS and control subjects were detected by quantitative polymerase chain reaction (qPCR). Expression of miR-133a was evaluated for sensitivity and specificity as an ACS biomarker diagnostic using the receiver operating characteristic (ROC) curve.RESULTS: Plasma miR-133a expression was stably found in ACS subjects. The plasma miR-133a level was lower in ACS than in control subjects. miR-133a effectively distinguished ACS subjects from healthy subjects (AUC=0.911) and exhibited high diagnostic performance, with a sensitivity of 87.1% and specificity of 100% at a cut-off value of 44.035. In an extended model including both control subjects (healthy and non-ACS with comorbid conditions), miR-133a maintained diagnostic significance (AUC=0.874), showing sensitivity of 76.9% and specificity of 100% at a cut-off value of 11.69.CONCLUSION: Plasma miR-133a is significantly lower and effectively distinguishes ACS patients from both healthy individuals and non-ACS individuals with comorbid, with a cut-off value of 11.69. Therefore, plasma miR-133a is suggested to be a good candidate for diagnostic biomarkers of ACS.KEYWORDS: circulating miRNA, miRNA-133a, acute coronary syndrome, diagnostic biomarker</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2024-10-28</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://doi.org/10.18585/inabj.v16i5.3243</dc:identifier><dc:identifier>10.18585/inabj.v16i5.3243</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 16 No 5 (2024); 464-472</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>